Antibe Therapeutics Inc (ATBPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Sales | 2,042 | 1,816 | 1,574 | 0 | 0 |
| Cost of Goods | 1,142 | 1,022 | 797 | N/A | N/A |
| Gross Profit | 899 | 794 | 777 | N/A | N/A |
| Operating Expenses | 1,935 | 2,036 | 2,137 | 579 | 310 |
| Operating Income | -894 | -1,220 | -562 | -579 | -310 |
| Interest Expense | 98 | 181 | 67 | 0 | 0 |
| Other Income | 98 | 178 | 68 | 2 | 1 |
| Pre-tax Income | -894 | -1,224 | -562 | -578 | -308 |
| Income Tax | -35 | -658 | -3 | N/A | N/A |
| Net Income Continuous | -859 | -566 | -559 | -578 | -308 |
| Net Income | $-859 | $-566 | $-559 | $-578 | $-308 |
| EPS Basic Total Ops | -0.08 | 0.00 | -0.07 | -0.15 | -0.08 |
| EPS Basic Continuous Ops | -0.11 | -0.07 | -0.08 | -0.12 | -0.06 |
| EPS Diluted Total Ops | -0.08 | 0.00 | -0.07 | -0.15 | -0.08 |
| EPS Diluted Continuous Ops | -0.11 | -0.07 | -0.08 | -0.12 | -0.06 |
| EBITDA(a) | $-730 | $-922 | $-496 | $-579 | $-310 |